Queen Elizabeth II and her wife to receive neocrown vaccine soon

On Sunday, Dec. 6, the Daily Mail reported that Queen Elizabeth II and her husband will be receiving the New Crown vaccine, a joint venture between Pfizer and BioNTech, within the next few weeks, due to their advanced age group and their desire to encourage people to get vaccinated. The Daily Mail report was reprinted by Agence France-Presse.

On Sunday, British Health Secretary Matt Hancock paid tribute to the national-level vaccination program that will begin next Tuesday. The U.K., one of the most affected countries in Europe, has approved the widespread distribution of the New Crown vaccine, a joint venture between Pfizer in the U.S. and BioNTech in Germany, a first in the Western world. Hancock named the UK’s vaccination launch day “V-Day,” the V corresponding to the English word for vaccine, “Vaccine,” and emphasized that “this is going to be a historic week! “The most vulnerable groups, people over the age of 80 and those who work in nursing homes and public health services, are vaccinated first.” According to a previous report released by the British government, the first batch of vaccines reached 800,000 doses, and the total number of vaccines scheduled for the UK is 40 million. In addition, in order to prevent any unpredictable policy changes during the Brexit transition period after December 31 of this year, the UK government has indicated that it will consider using military aircraft to deliver the vaccines in the event of a land traffic jam. So far, there is still no light at the end of the tunnel for negotiations between the U.K. and the European Union on their post-separation relationship, with three main disputes: fisheries exploitation management, fair competition guarantees, and future dispute resolution mechanisms.

The Daily Mail reports that Queen Elizabeth II, 94, and her husband, Prince Philip, 99, will also be vaccinated in the next few weeks to encourage the public to get vaccinated. The British government had previously raised concerns about the public’s acceptance of the vaccine. Although the U.K. fast-tracked the licensing of the new Crestor vaccine, the head of the U.K. Medicines and Health Products Regulatory Agency (MHRA), Mr. Ryan, reiterated on Sunday via the BBC that the U.K. was applying the “highest international standards” when approving the vaccine.